Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study.
暂无分享，去创建一个
B. Costello | E. Lam | A. Bryce | V. Narayan | D. Bossé | R. McKay | A. Mortazavi | P. Boland | Junxiao Hu | T. Rose | K. Collier | Corbin J. Eule | Sulaiman Al-Saad | Akeem R. Lewis | Akeem R Lewis